ARTICLE | Company News
Drugs for Neglected Diseases, Takeda deal
September 14, 2015 7:00 AM UTC
DNDi and Takeda partnered to identify the best candidate from an aminopyrazole series of small molecules to treat visceral leishmaniasis. The Global Health Innovative Technology (GHIT) Fund (Tokyo, J...